在治疗肝癌的分子标和纳米技术方法
Trilochan Satapathy1, Maneesh Kumar Diwakar1
1Department of Pharmacology, Columbia Institute of Pharmacy, Tekari, Raipur, Chhattisgarh, 493111, India.
Current cancer drug targets
|November 1, 2024
概括
纳米技术为肝癌治疗提供了有前途的策略,特别是肝细胞癌 (HCC). 本综述探讨了在药物输送系统中的无机和碳基纳米粒子,以改善检测和治疗.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
背景情况:
- 肝癌,特别是肝细胞癌 (HCC),是全球癌症死亡的主要原因.
- 手术切除瘤并不总是可行的,需要替代治疗策略.
- 纳米粒子 (NP) 正在研究它们在肝癌治疗中的潜力.
研究的目的:
- 用纳米技术提供HCC检测和治疗近期进展的简要概述.
- 阐明HCC中纳米材料研究的现状.
- 突出纳米技术在HCC管理中的局限性和未来潜力.
主要方法:
- 对HCC的当前研究和临床诊断指南的审查.
- 在药物输送系统 (DDS) 中对无机纳米粒子 (例如,银,金,金属氧化物) 的详细检查.
- 在DDS中用于HCC处理的碳基纳米粒子 (聚合物,多糖,脂质,碳点) 的讨论.
主要成果:
- 各种无机和碳基NP显示出在HCC中具有治疗,载体和成像应用的潜力.
- 纳米技术融入DDS是改善肝癌治疗的关键重点.
- 研究正在探索各种纳米材料,以提高有效性和有针对性的交付.
结论:
- 纳米技术在推进HCC的检测和治疗方面具有重大前景.
- 进一步研究纳米材料的局限性和未来的进步至关重要.
- 纳米技术在DDS中的整合对于改善肝癌患者的治疗结果至关重要.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
